15-Jan-2025 5:30 AM CST - Yahoo Finance Henry Schein Completes Acquisition of Acentus The Acentus transaction follows Henry Schein's acquisition of Prism Medical Products, LLC in 2021 and Shield Healthcare and Mini Pharmacy in 2023, reinforcing the Company's strategic commitment to the homecare medical supplies market. Henry Schein's homecare medical products platform will now have an annual revenue base in excess of $350 million.
14-Jan-2025 4:44 AM CST - Yahoo Finance Calculating The Fair Value Of Henry Schein, Inc. (NASDAQ:HSIC) The projected fair value for Henry Schein is US$67.04 based on 2 Stage Free Cash Flow to Equity With US$70.70 share price, Henry Schein appears to be trading close to its estimated fair value
6-Jan-2025 12:15 PM CST - MSN B of A Securities Upgrades Henry Schein (HSIC) Fintel reports that on January 6, 2025, B of A Securities upgraded their outlook for Henry Schein (NasdaqGS:HSIC) from Underperform to Buy. Analyst Price Forecast Suggests 9.79% Upside As of December 23,
6-Jan-2025 5:09 AM CST - Business Insider Henry Schein upgraded to Buy from Underperform at BofA BofA upgraded Henry Schein (HSIC) to Buy from Underperform with an $84 price target Don't Miss Our New Year's Offers:Discover the latest stocks
2-Jan-2025 9:26 AM CST - Zacks Henry Schein Stock to Gain From New Acquisitions Amid Macro Woes Henry Schein HSIC is well positioned to gain from its extensive global foothold and diverse channel mix. Yet, global economic uncertainties are concerns for Henry Schein. The stock carries a Zacks Rank #3 (Hold) currently.
30-Dec-2024 7:40 AM CST - Barchart Is Henry Schein Stock Underperforming the S&P 500? Valued at a market cap of $8.8 billion, Henry Schein, Inc. (HSIC) provides healthcare products and services to dental practitioners, laboratories, physician practices, ambulatory surgery centers, government,
19-Dec-2024 6:23 AM CST - Yahoo Finance Should You Retain Henry Schein Stock in Your Portfolio Right Now? The leading distributor of healthcare products and services has a market capitalization of $9.12 billion. Henry Schein surpassed estimates in three of the trailing four quarters and missed the same in one, delivering an average earnings surprise of 2.85%. Find the latest EPS estimates and surprises on Zacks Earnings Calendar.
17-Dec-2024 10:30 AM CST - Benzinga How Is The Market Feeling About Henry Schein? Henry Schein's HSIC short percent of float has risen 3.96% since its last report. The company recently reported that it has 6.45 million shares sold short, which is 5.77% of all regular shares that are available for trading. Based on its trading volume, it would take traders 2.76 days to cover their short positions on average.
5-Dec-2024 11:45 AM CST - MSN Henry Schein (HSIC) Up 6.4% Since Last Earnings Report: Can It Continue? It has been about a month since the last earnings report for Henry Schein (HSIC). Shares have added about 6.4% in that time frame, outperforming the S&P 500. Will the recent positive trend continue leading up to its next earnings release,
15-Jan-2025 5:30 AM CST - Yahoo Finance Henry Schein Completes Acquisition of Acentus The Acentus transaction follows Henry Schein's acquisition of Prism Medical Products, LLC in 2021 and Shield Healthcare and Mini Pharmacy in 2023, reinforcing the Company's strategic commitment to the homecare medical supplies market. Henry Schein's homecare medical products platform will now have an annual revenue base in excess of $350 million.
14-Jan-2025 4:44 AM CST - Yahoo Finance Calculating The Fair Value Of Henry Schein, Inc. (NASDAQ:HSIC) The projected fair value for Henry Schein is US$67.04 based on 2 Stage Free Cash Flow to Equity With US$70.70 share price, Henry Schein appears to be trading close to its estimated fair value
6-Jan-2025 12:15 PM CST - MSN B of A Securities Upgrades Henry Schein (HSIC) Fintel reports that on January 6, 2025, B of A Securities upgraded their outlook for Henry Schein (NasdaqGS:HSIC) from Underperform to Buy. Analyst Price Forecast Suggests 9.79% Upside As of December 23,
6-Jan-2025 5:09 AM CST - Business Insider Henry Schein upgraded to Buy from Underperform at BofA BofA upgraded Henry Schein (HSIC) to Buy from Underperform with an $84 price target Don't Miss Our New Year's Offers:Discover the latest stocks
2-Jan-2025 9:26 AM CST - Zacks Henry Schein Stock to Gain From New Acquisitions Amid Macro Woes Henry Schein HSIC is well positioned to gain from its extensive global foothold and diverse channel mix. Yet, global economic uncertainties are concerns for Henry Schein. The stock carries a Zacks Rank #3 (Hold) currently.
30-Dec-2024 7:40 AM CST - Barchart Is Henry Schein Stock Underperforming the S&P 500? Valued at a market cap of $8.8 billion, Henry Schein, Inc. (HSIC) provides healthcare products and services to dental practitioners, laboratories, physician practices, ambulatory surgery centers, government,
19-Dec-2024 6:23 AM CST - Yahoo Finance Should You Retain Henry Schein Stock in Your Portfolio Right Now? The leading distributor of healthcare products and services has a market capitalization of $9.12 billion. Henry Schein surpassed estimates in three of the trailing four quarters and missed the same in one, delivering an average earnings surprise of 2.85%. Find the latest EPS estimates and surprises on Zacks Earnings Calendar.
17-Dec-2024 10:30 AM CST - Benzinga How Is The Market Feeling About Henry Schein? Henry Schein's HSIC short percent of float has risen 3.96% since its last report. The company recently reported that it has 6.45 million shares sold short, which is 5.77% of all regular shares that are available for trading. Based on its trading volume, it would take traders 2.76 days to cover their short positions on average.
5-Dec-2024 11:45 AM CST - MSN Henry Schein (HSIC) Up 6.4% Since Last Earnings Report: Can It Continue? It has been about a month since the last earnings report for Henry Schein (HSIC). Shares have added about 6.4% in that time frame, outperforming the S&P 500. Will the recent positive trend continue leading up to its next earnings release,
